Navigation Links
Public prefers limited informed consent process for biobanks
Date:6/28/2011

ion is important because opt-in consent typically involves more detail, more time and a more active decision on research participation when compared to an opt-out process," Simon explained.

Sixty-seven percent of those surveyed and 63 percent of those who participated in the focus groups said they would prefer an opt-in consent process.

"Nonetheless," Simon said, "a substantial minority -- 18 percent in the surveys and 25 percent in the focus groups -- said they would prefer an opt-out process, primarily because they felt it provided at least some level of choice, involved less time for potential donors and fewer resources for the biobank, and would help with sample accrual and therefore also medical research and progress."

Study participants were then asked to consider whether they would prefer a broad description of how their samples and health information might be used in future research, whether they wanted to control what research their samples and health information are used in via "menu-type" consent forms, or whether they wanted to be contacted for their permission every time their samples and health information became eligible for research.

"Broad consent was preferred by more people when compared to either the menu or study-specific types of consent," Simon said. "However, if you were to lump together the people who said they preferred the menu and study-specific types of consent on the grounds that both these approaches promote more control over sample use than broad consent, the margin is not so impressive."

Forty-one percent of people surveyed and 54 percent of those in focus groups were in favor of the broad approach to providing consent.

Simon noted that some experts have suggested that more than one consent approach should be offered to people to allow for a diversity of consent preferences.

"Of course, there may be significant cost and logistic implications to creating such multip
'/>"/>

Contact: Molly Rossiter
molly-rossiter@uiowa.edu
319-356-7127
University of Iowa Health Care
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Scripps Research Institute Scientist Knighted by Italian Republic
2. Grant funds science career days for Philadelphia public school students
3. Public and private sectors unite to make more of brewing by-products
4. Democrats and Republicans increasingly divided over global warming
5. Public forum: Japan and early lessons for the nuclear industry
6. Zimmerman receives Richard King Trainee Award for best publication in genetics in medicine
7. Science reporter wins ASM Public Communications Award
8. Publics budget priorities differ dramatically from House and Obama
9. Clinical Benefits of Zimmers DeNovo® NT Natural Tissue Graft in First Surgery Documented in Peer-Reviewed Publication
10. Immunologist J. John Cohen receives the 2010 AAAS Public Understanding of Science and Technology Award
11. Tufts announces public launch of the Tufts Institute for Biomedical Partnerships website/HUB
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... 2014)The Brain & Behavior Research Foundation today announced ... Prizes, recognizing exceptional clinical and basic research by ... Young Investigator Grants. The grants enable early career ... psychosocial research for the prevention, early detection, treatment, ... in four people. , Six young scientistswinners of ...
(Date:7/28/2014)... from fertility problems, many of these due to genetic ... expect such genes, which reduce an individual,s ability to ... Weizmann Institute of Science that recently appeared in ... Not only can it explain the high rates of ... understanding the causes of genetic diseases and their treatment. ...
(Date:7/27/2014)... that nicotine and cotinine, a metabolite of nicotine, can ... in smoke. , The carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone or NNK is ... ends up in the tobacco smoke. Once inhaled, it ... is activated by a variety of enzymes called Cytochrome ... nicotine can partially interfere with the activation of NNK, ...
Breaking Biology News(10 mins):The Brain & Behavior Research Foundation names winners of Klerman and Freedman Prizes 2The Brain & Behavior Research Foundation names winners of Klerman and Freedman Prizes 3The Brain & Behavior Research Foundation names winners of Klerman and Freedman Prizes 4Mutations from Venus, mutations from Mars 2Nicotine found to inhibit DNA-strand break caused by a certain carcinogen in smoke 2
... Pathological gambling can be successfully treated with medications ... researchers at the annual meeting of the American ... outcomes in gamblers treated with medications often used ... pathological gambling disorder will continue their gambling behavior ...
... well-known for his book On the Origin of Species, in ... contributed to many specific fields within biology. As the ... December issue of the American Journal of Botany ... Darwin, Darwin,s contributions to botany, and what scientists have discovered ...
... across the vast expanses of the ocean to attract potential ... decades, and a scientist at Scripps Institution of Oceanography at ... be good news for the population of the endangered marine ... with John Hildebrand of Scripps Oceanography and Sarah Mesnick of ...
Cached Biology News:Pathological gambling may be successfully treated with medications for substance addiction 2Charles Darwin: More than the origin 2Charles Darwin: More than the origin 3The pitch of blue whale songs is declining around the world, scientists discover 2The pitch of blue whale songs is declining around the world, scientists discover 3
(Date:7/28/2014)... MA (PRWEB) July 28, 2014 Immunomic ... two researchers to further develop potential treatments for glioblastoma ... tumor, in combination with their patented vaccine platform, LAMP-vax. ... Duke University, are based on the work of John ... Neurosurgery at The Preston Robert Tisch Brain Tumor Center ...
(Date:7/28/2014)... Appistry, Inc. , a leading ... power of genomics to next-generation medicine, announced today its ... . , Two Appistry staff will be joined ... for Genome Resources, and Mr. Neil Miller, director of ... City. Rounding out the panel are Appistry’s Dr. Richard ...
(Date:7/28/2014)... California (PRWEB) July 28, 2014 The ... 604.40 billion by 2020, according to a new study ... with the rising demand for effective vaccines and drugs ... with unmet medical needs is expected to drive market ... need to enhance agricultural productivity via the use of ...
(Date:7/28/2014)... and COLLEGE STATION, Texas , July ... hotel theatlashotel.com will be a 177-key, 4-star boutique hotel ... Bryan , Texas.  Photo - ... As the first hotel within ATLAS ... 177 rooms, a mixture of standard rooms and suites, a sleek ...
Breaking Biology Technology:String of Collaborations Launch Immunomic Therapeutics’ Brain Tumor Program Pipeline 2String of Collaborations Launch Immunomic Therapeutics’ Brain Tumor Program Pipeline 3String of Collaborations Launch Immunomic Therapeutics’ Brain Tumor Program Pipeline 4Appistry Names Industry Experts from the National Center for Genome Resources and Mercy Children's, Kansas City, to Judge Pipeline Challenge Competition 2Global Biotechnology Market Worth $604.40 Billion by 2020: Grand View Research, Inc 2Global Biotechnology Market Worth $604.40 Billion by 2020: Grand View Research, Inc 3Global Biotechnology Market Worth $604.40 Billion by 2020: Grand View Research, Inc 4Texas' Biocorridor Announces the Atlas Hotel, Centerpiece of Mixed Use Community for Biotech Industry 2Texas' Biocorridor Announces the Atlas Hotel, Centerpiece of Mixed Use Community for Biotech Industry 3Texas' Biocorridor Announces the Atlas Hotel, Centerpiece of Mixed Use Community for Biotech Industry 4
... Feb. 28 InterMune, Inc.,(Nasdaq: ITMN ) ... Officer of InterMune, will present at Susquehanna,s Second ... on March 5, 2008,at 2:30 p.m. EST., ... presentation, investors and other,interested parties may log on ...
... ... Feb. 28 Cepheid (Nasdaq:,CPHD) today announced financial results for the fourth quarter and full,year ... Total revenues of $129.5 million, a 48 percent increase from $87.4 ... - Total product sales of $116.5 million, a 41 percent increase from ...
... N.C., Feb. 28 PPD, Inc. (Nasdaq:,PPDI) today ... (NDA) for alogliptin, a highly selective DPP-4 inhibitor ... accepted for filing by the U.S.,Food and Drug ... Under PPD,s agreement with Takeda, the FDA,s ...
Cached Biology Technology:InterMune to Present at the SIGnificant Options in Healthcare Conference 2Cepheid Reports Fourth Quarter and Full Year 2007 Results 2Cepheid Reports Fourth Quarter and Full Year 2007 Results 3Cepheid Reports Fourth Quarter and Full Year 2007 Results 4Cepheid Reports Fourth Quarter and Full Year 2007 Results 5Cepheid Reports Fourth Quarter and Full Year 2007 Results 6Cepheid Reports Fourth Quarter and Full Year 2007 Results 7Cepheid Reports Fourth Quarter and Full Year 2007 Results 8Cepheid Reports Fourth Quarter and Full Year 2007 Results 9Cepheid Reports Fourth Quarter and Full Year 2007 Results 10Cepheid Reports Fourth Quarter and Full Year 2007 Results 11Cepheid Reports Fourth Quarter and Full Year 2007 Results 12Cepheid Reports Fourth Quarter and Full Year 2007 Results 13Cepheid Reports Fourth Quarter and Full Year 2007 Results 14PPD Confirms Takeda's NDA Filing of Alogliptin with U.S. Food and Drug Administration 2
... monoclonal [6331] to Salmonella typhimurium The genus ... The genus is composed of Gram-negative bacilli that ... major antigens; the "H" or flagellar antigen (phase ... (part of the LPS moiety) and the "Vi" ...
... sodium pyruvate, 50 mg/L streptomycin sulfate, 100 ... chloride, and magnesium chloride. The use of ... culture is generally attributed to early workers ... developed a solution of inorganic salts designed ...
... is a dramatic breakthrough in accurate, small-volume bulk ... resolution, the micro 1 has unique advantages not ... micro 1 never needs re-calibration as do other ... on an LCD Display , Graphical Row Selection ...
... ( Abpromise for all tested ... Synthetic peptide: VEEESFGPQPISRLE conjugated to KLH, ... 15-29 of Human Rad51 ... Swiss Protein ID: ...
Biology Products: